Search for: "Boehringer-Ingelheim" Results 41 - 60 of 441
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Aug 2012, 2:29 pm
Melvin Giles, Jr. sued Boehringer Ingelheim in the U.S. [read post]
20 Oct 2021, 12:12 pm by Khadijah M. Silver
Boehringer Ingelheim has shown biosimilar manufacturers the way to win interchangeability with the world’s highest-grossing drug — but the company’s Cyltezo won't come out until July 2023. [read post]
29 Jun 2008, 10:23 am
Boehringer Ingelheim sued Barr and Mylan for infringing 4,886,812 after the two filed ANDAs seeking to market generic versions of Mirapex, used to treat Parkinson's disease. [read post]
22 Mar 2012, 1:15 pm by Tom Lamb
This January 17, 2012 FDA approval letter to Boehringer Ingelheim shows the revisions to the Pradaxa Prescring Information, or label, that would be made in the U.S. [read post]
5 Jan 2014, 5:43 pm by Bob Briskman
More than 1,700 personal injury lawsuits are pending against pharmaceutical company Boehringer Ingelheim in Illinois. [read post]
21 Mar 2014, 7:59 am by Robert Kraft
Bloomberg News reported Boehringer Ingelheim GmbH failed to reveal “a data analysis to U.S. regulators that” suggested the blood-thinner Pradaxa “may have caused more fatal bleeding after it was cleared for sale than the drug did in a study used to win approval,” citing unsealed court filings. [read post]
26 Oct 2021, 12:41 am by Florence Plisner (Bristows)
On 8 October 2021, His Honour Judge Hacon (sitting as a Judge of the High Court) handed down his decision in an action brought by Royalty Pharma Collection Trust (“Royalty Pharma”) for approximately €23 million in royalty payments from Boehringer Ingelheim GmbH (“Boehringer”) (Royalty Pharma Collection Trust v Boehringer Ingelheim GmbH [2021] EWHC 2692 (Pat)). [read post]
26 Oct 2021, 12:41 am by Florence Plisner (Bristows)
On 8 October 2021, His Honour Judge Hacon (sitting as a Judge of the High Court) handed down his decision in an action brought by Royalty Pharma Collection Trust (“Royalty Pharma”) for approximately €23 million in royalty payments from Boehringer Ingelheim GmbH (“Boehringer”) (Royalty Pharma Collection Trust v Boehringer Ingelheim GmbH [2021] EWHC 2692 (Pat)). [read post]
4 Jan 2016, 3:30 am by Laura Gaze
In fact, several of the companies new to this year’s ranking of top innovators have been around a lot longer than Amazon, among them: Boehringer Ingelheim, Chevron, Exxon Mobil, Johnson Controls, Thales, and Yamaha. [read post]
28 Sep 2021, 7:37 am by Ronald V. Miller, Jr.
But projecting settlement amounts is what stock analysts and shareholders for Sanofi-Aventis, Boehringer Ingelheim, Pfizer, and GlaxoSmithKline are already doing and baking those costs into the stock price. [read post]
25 Oct 2010, 9:55 pm by Patent Docs
Boehringer Ingelheim 1:10-cv-01767; filed October 19, 2010 in the District Court of the District of Columbia Declaratory judgment of invalidity and non-infringement of U.S. [read post]
14 Mar 2014, 7:33 am by Robert Kraft
The maker, Boehringer Ingelheim, faces “thousands of lawsuits” over the drug, which was approved in 2010 and generated $2 billion in sales. [read post]
30 May 2014, 8:13 am
German pharmaceutical company Boehringer Ingelheim has agreed to pay $650 million to settle thousands of consumer lawsuits involving its blood thinner medication Pradaxa. [read post]
31 May 2014, 8:18 am by Dr. Shezad Malik
Germany based Boehringer Ingelheim, the manufacturer of the anticoagulant medication Pradaxa has agreed to pay $650 million to settle Pradaxa injury lawsuits. [read post]
3 Jun 2014, 4:41 pm
That same year, Boehringer Ingelheim Pharmaceuticals, Inc. made $1.5 billion in sales of Pradaxa. [read post]
13 Feb 2014, 6:00 am by LTA-Editor
District Court Judge David Herndon from the Southern District of Illinois imposed close to $1 million in punitive damages on defendants Boehringer Ingelheim International GMBH (“BII”) and Boehringer Ingelheim Pharmaceuticals, Inc. [read post]